Nanollose Limited (NC6.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -348.95 Thousand AUD | -698.66% |
| 2023 | 58.28 Thousand AUD | -621.59% |
| 2022 | -223.55 Thousand AUD | -39.98% |
| 2021 | -70.57 Thousand AUD | -34.88% |
| 2020 | -12.71 Thousand AUD | 100.46% |
| 2019 | -489.56 Thousand AUD | 83.94% |
| 2018 | -493.44 Thousand AUD | 22979.13% |
| 2017 | -299.41 Thousand AUD | -104.16% |
| 2016 | 11.63 Thousand AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -779.19 Thousand AUD | 6.4% |
| 2024 Q2 | -426.65 Thousand AUD | -74.33% |
| 2024 Q4 | -121.27 Thousand AUD | -289.9% |
| 2023 Q2 | -26.18 Thousand AUD | 0.0% |
| 2023 Q4 | -376.12 Thousand AUD | 0.0% |
| 2023 FY | -832.5 Thousand AUD | -621.59% |
| 2022 Q2 | -32.15 Thousand AUD | 0.0% |
| 2022 FY | 159.6 Thousand AUD | -39.98% |
| 2022 Q4 | 191.75 Thousand AUD | 0.0% |
| 2021 Q4 | 292.41 Thousand AUD | 0.0% |
| 2021 Q2 | -26.5 Thousand AUD | 0.0% |
| 2021 FY | 265.91 Thousand AUD | -34.88% |
| 2020 Q2 | 434.85 Thousand AUD | 0.0% |
| 2020 FY | 408.32 Thousand AUD | 100.46% |
| 2020 Q4 | -26.53 Thousand AUD | 0.0% |
| 2019 FY | 203.68 Thousand AUD | 83.94% |
| 2019 Q4 | 218.36 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 FY | 110.73 Thousand AUD | 22979.13% |
| 2018 Q4 | -493.44 Thousand AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q4 | -299.41 Thousand AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2017 FY | -484.00 AUD | -104.16% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | 11.63 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Memphasys Limited | 1606.00 AUD | 21828.02% |
| Race Oncology Limited | 1.38 Million AUD | 125.106% |
| AdAlta Limited | 1.5 Million AUD | 123.141% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 53.405% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | -15.758% |
| BTC Health Limited | 16.36 Thousand AUD | 2232.958% |
| CSL Limited | 15.28 Billion AUD | 100.002% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 103.033% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 115.069% |
| Imugene Limited | -5.83 Million AUD | 94.025% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -282.049% |
| PharmAust Limited | -1641.00 AUD | -21164.595% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 68.932% |
| Acrux Limited | -1.28 Million AUD | 72.823% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 94.674% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.447% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 127.881% |
| Nyrada Inc. | -5164.07 AUD | -6657.306% |
| Orthocell Limited | 3.68 Million AUD | 109.461% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 98.362% |
| Starpharma Holdings Limited | 7.65 Million AUD | 104.557% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 3493.154% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -1243.208% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 109.171% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 108.7% |
| Biome Australia Limited | 7.66 Million AUD | 104.55% |
| Biotron Limited | -40.49 Thousand AUD | -761.652% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 104.682% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 100.685% |
| Immutep Limited | 1.44 Million AUD | 124.167% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 128.785% |
| Noxopharm Limited | -534.81 Thousand AUD | 34.752% |
| Patrys Limited | 1.39 Million AUD | 125.029% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 109.4% |
| PYC Therapeutics Limited | 22.05 Million AUD | 101.582% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.113% |
| Dimerix Limited | 583.47 Thousand AUD | 159.806% |
| Hexima Limited | - AUD | Infinity% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.17% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 331.845% |
| AnteoTech Limited | 460.39 Thousand AUD | 175.794% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 714.222% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 4.858% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -696.785% |
| Actinogen Medical Limited | 9.93 Million AUD | 103.514% |
| Immuron Limited | 3.33 Million AUD | 110.458% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 113.432% |